Connect with us:
Life Line Screening Life Line Screening
Life Line Screening
Contact Us 866.895.3336
7 million health screenings since 1993
Healthy Living
Healthy You
Health News


.

Check availability and
schedule a screening

Enter a US Zip Code

 

Health Highlights

A FREE monthly newsletter customized for you - featuring these topics:
Diabetes
High Blood Pressure
Weight Loss
High Cholesterol 

Update Your Subscription
New Subscribers - Click Here!

Scans May Aid Early Detection of Dementia, Parkinson's

Text Font
Small Text Medium Text Large Text

Imaging tests spotted brain abnormalities before noticeable symptoms developed in study patients.

Scans May Aid Early Detection of Dementia, Parkinson's
HealthDay

Life Line Screening does not offer these imaging tests. We bring you this information for educational purposes only.

Brain imaging may help identify sleep disorder patients at greatest risk for neurodegenerative diseases such as dementia and Parkinson's disease, an international team of researchers has found.

Their study of people with rapid-eye-movement sleep behavior disorder (IRBD) found that brain imaging tests can detect neurodegenerative disease-related brain abnormalities before a person develops noticeable symptoms.

Previous research has shown that IRBD of unknown cause may be an early predictor of neurodegenerative diseases in more than half of patients, but it hasn't been possible to identify which patients will develop these diseases.

Being able to identify IRBD patients at increased risk would lead to earlier treatment and improve understanding of the early stages of neurodegenerative diseases, according to Alex Iranzo de Riquer, of the Hospital Clinic of Barcelona, and colleagues.

At the start of the study, 43 patients with IRBD underwent two brain imaging tests -- dopamine transporter imaging and transcranial sonography.

Of the 27 patients whose imaging tests showed brain abnormalities associated with Parkinson's and a brain disease known as dementia with Lewy bodies, eight (30 percent) had developed a neurodegenerative disease when assessed 2-1/2 years later. Five had Parkinson's disease; two had dementia with Lewy bodies; and one had multiple system atrophy, a rare condition that affects movement, balance and other bodily functions.

The patients without brain abnormalities (and 70 percent of those with such abnormalities) remained disease-free at the end of the study.

The study findings were released online Sept. 14 in advance of publication in the November print issue of The Lancet Neurology.

SCHEDULE A SCREENING

Source:

The Lancet Neurology, news release, Sept. 14, 2010

Introducing:
Update your subscription to receive your FREE personalized monthly newsletter - featuring these topics:
Diabetes High Blood Pressure
Weight Loss High Cholesterol
Health Highlights
Update Your Subscription
New Subscribers - Click Here!
PrintPrint the page Send-to-Friend Send to friend Comments 0 Comments | Add/Show Comments Bookmark and Share

 

US Home | About Us | Press Room | Partners | Healthy Living | Blog | Health Facts | Privacy Policy | Terms of Service | Site Map | Contact Us | Careers | Life Line Screening UK | Life Line Screening Wellness | Employee Access | Prescription Savings Program | Hospital Partnership Program
© Life Line Screening of America. All Rights Reserved.